Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Phyllis Jackson

Physician Assistant Glen Mills, PA Physician Assistant

NPI 1043649627 CMS profile 10742011

300 Evergreen Dr, Suite 150, Glen Mills, PA 19342

Open in the dashboard

General payments

$5,081

270 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Phyllis Jackson of Glen Mills, PA is reported in the CMS Open Payments database as having received $5,081 across 270 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $476 24
2024 General $365 21
2023 General $740 38
2022 General $1,653 86
2021 General $1,848 101

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Phyllis Jackson
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Phyllis Jackson were reported at $476. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Phyllis Jackson Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,848 $132 $37–$438 $132
2022 $1,653 $155 $48–$522 $149
2023 $740 $167 $52–$557 $160
2024 $365 $178 $55–$600 $164
2025 $476 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $854 52 payments
  2. Harmony Biosciences LLC $427 16 payments
  3. Teva Pharmaceuticals USA, Inc. $384 22 payments
  4. UCB, Inc. $362 16 payments
  5. Biohaven Pharmaceutical Holding Company Ltd. $344 18 payments
  6. Jazz Pharmaceuticals Inc. $288 15 payments
  7. Biohaven Pharmaceuticals, Inc. $279 20 payments
  8. Lilly USA, LLC $266 15 payments
  9. Acorda Therapeutics, Inc $182 9 payments
  10. Amgen Inc. $179 9 payments
  11. Other $1,515 78 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,997 266 payments
  2. Education $60 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23 1 payment
Products named General payments · program years 2021–2025
  1. NURTEC ODT $623 38 payments
  2. UBRELVY $486 29 payments
  3. Wakix $359 13 payments
  4. QULIPTA $300 20 payments
  5. XYWAV $264 14 payments
  6. Briviact $259 11 payments
  7. AJOVY $181 9 payments
  8. AIMOVIG $179 9 payments
  9. EMGALITY $166 9 payments
  10. INBRIJA $159 8 payments
  11. Other $2,362 125 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

316

Median for Physician Assistant: 241

Drug cost

$14,631

Median for Physician Assistant: $4,110

Branded share of claims

7.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Aimovig Autoinjector Erenumab-Aooe Brand 11 $9,007
Memantine Hcl Generic 127 $2,825
Rivastigmine Generic 14 $1,068
Donepezil Hcl Generic 39 $576
Clopidogrel Clopidogrel Bisulfate Brand 14 $303
Gabapentin Generic 35 $258
Topiramate Generic 28 $201
Quetiapine Fumarate Generic 12 $174
Duloxetine Hcl Generic 13 $132
Sumatriptan Succinate Generic 23 $87

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$18,642

Medicare's payments for the services billed

Medicare patients

97

Average age 75

Services billed

193

51 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Diabetes 37%
Ischemic heart disease 36%
Chronic kidney disease 36%
Atrial fibrillation 31%
Alzheimer's or dementia 28%
Depression 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 20 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Zilbrysq
  • UCB, Inc. $37
$37 — —
QULIPTA
  • AbbVie, Inc. $35
$35 — —
Leqembi
  • Eisai Inc. $33
$33 — —
BOTOX
  • AbbVie, Inc. $21
$21 — —
HYQVIA
  • Takeda Pharmaceuticals U.S.A., Inc. $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 20 in the dashboard with a free account

Records

270 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record